PLAU and prostate carcinoma: In the present study, results revealed that PTEN silencing conferred CRC cells with an enhanced invasive capacity to migrate in vitro probably by inducing the expression of MMP-2, MMP-9 and uPA as it has already been observed in prostate cancer cells [66].